Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Invested Capital (2021 - 2025)

Roivant Sciences' Return on Invested Capital history spans 5 years, with the latest figure at 0.27% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 106.0% year-over-year to 0.27%; the TTM value through Dec 2025 reached 0.27%, down 106.0%, while the annual FY2025 figure was 0.21%, 86.0% down from the prior year.
  • Return on Invested Capital reached 0.27% in Q4 2025 per ROIV's latest filing, down from 0.25% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.97% in Q4 2023 to a low of 0.75% in Q3 2022.
  • Average Return on Invested Capital over 5 years is 0.15%, with a median of 0.32% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 162bps in 2023, then plummeted -106bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.53% in 2021, then fell by -22bps to 0.65% in 2022, then skyrocketed by 250bps to 0.97% in 2023, then fell by -19bps to 0.79% in 2024, then crashed by -134bps to 0.27% in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Return on Invested Capital are 0.27% (Q4 2025), 0.25% (Q3 2025), and 0.21% (Q2 2025).